Voltage-Gated Potassium Channel (VGKC) Antibody




Test Mnemonic

VGKCAB

CPT Codes

  • 83519 - QTY (1)

LOINC ®

41871-5

Performing Laboratory

ARUP

FDA Category

Laboratory Developed Test


Specimen Requirements

Volume Type Container Collect Temperature Transport Temperature Special Instructions
4 mLSerumSST (Gold) RefrigeratedSeparate serum from cells within 1 hour of collection.

Alternate Specimen Requirements

Volume Type Container Collect Temperature Transport Temperature Special Instructions
4 mLSerumNo additive (Red) RefrigeratedSeparate serum from cells within 1 hour of collection.

Minimum Specimen Requirements

Volume Type Container Collect Temperature Transport Temperature Special Instructions
0.5 mL     

Stability

Environmental Condition Description
RefrigeratedAfter separation from cells: 2 weeks
FrozenAfter separation from cells: 1 month (Avoid repeated freeze/thaw cycles)
AmbientAfter separation from cells: 72 hours

Days Performed

Tue

Turnaround Time

2 - 9 days

Methodology

Name Description
Quantitative Radioimmunoassay 

Reference Range

Volt Gated K Chan Ab
Sex Age From Age To Type Range Range Unit
       NormalNegative: <= 31pmol/L
       NormalIndeterminate: 32 - 87pmol/L
       NormalPositive: >= 88pmol/L

Special Info

Screening test for Voltage-Gated Potassium Channel (VGKC) antibody receptor complex-associated autoantibodies. Assay does not identify Contactin Associated Protein 2 (CASPR2) Antibody or Leucine-rich Glioma Inactivated 1 Protein (LGI1) antibodies individually. Plasma is unacceptable. Grossly lipemic or icteric specimens will be rejected.

Clinical Info

Voltage-Gated Potassium Channel (VGKC) antibodies are associated with neuromuscular weakness as found in neuromyotonia (also known as Issacs syndrome) and Morvan syndrome. VGKC antibodies are also associated with paraneoplastic neurological syndromes and limbic encephalitis; however, VGKC antibody-associated limbic encephalitis may be associated with antibodies to leucine-rich, glioma-inactivated 1 protein (Lgi1) or contactin-associated protein-2 (Caspr-2) instead of potassium channel antigens.The clinical significance of this test can only be determined in conjunction with the patient's clinical history and related laboratory testing.